Share
Market Research Report

OREXIN RECEPTOR AGONIST THERAPEUTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By Receptor TargetOrexin 2 Receptor (OX2R) Agonists · Dual Orexin 1 and 2 Receptor (OX1R/OX2R) Agonists · Orexin 1 Receptor (OX1R) Agonists
  • By Molecule TypeSmall Molecules · Peptide-Based Molecules
  • By Route of AdministrationOral · Intravenous · Others
  • By IndicationNarcolepsy Type 1 · Narcolepsy Type 2 · Idiopathic Hypersomnia · Other Neurological and Sleep-Wake Disorders
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East · and Africa
  • Published In18 Nov 2026
  • Report CodeCMI10433
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global Orexin Receptor Agonist Therapeutics Market, By Receptor Target
      • Global Orexin Receptor Agonist Therapeutics Market, By Molecule Type
      • Global Orexin Receptor Agonist Therapeutics Market, By Route of Administration
      • Global Orexin Receptor Agonist Therapeutics Market, By Indication
      • Global Orexin Receptor Agonist Therapeutics Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Receptor Target Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Market Opportunities
    • Industry Trends
  4. Global Orexin Receptor Agonist Therapeutics Market, By Receptor Target, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Orexin 2 Receptor (OX2R) Agonists
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Dual Orexin 1 and 2 Receptor (OX1R/OX2R) Agonists
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Orexin 1 Receptor (OX1R) Agonists
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  5. Global Orexin Receptor Agonist Therapeutics Market, By Molecule Type, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Small Molecules
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Peptide-Based Molecules
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  6. Global Orexin Receptor Agonist Therapeutics Market, By Route of Administration, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Intravenous
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  7. Global Orexin Receptor Agonist Therapeutics Market, By Indication, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Narcolepsy Type 1
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Narcolepsy Type 2
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Idiopathic Hypersomnia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Other Neurological and Sleep-Wake Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  8. Global Orexin Receptor Agonist Therapeutics Market, By Region, 2021 - 2033, Value (USD Mn)

    • Introduction
      • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Receptor Target, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Molecule Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Indication,2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Receptor Target, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Molecule Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Indication,2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Receptor Target, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Molecule Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Indication,2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Receptor Target, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Molecule Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Indication,2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Receptor Target, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Molecule Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Indication,2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Receptor Target, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Molecule Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Indication,2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
        • South Africa
        • North Africa
        • Central Africa
  9. Competitive Landscape

    • Takeda Pharmaceutical Company Limited
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Harmony Biosciences Holdings, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Eli Lilly and Company
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Alkermes plc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Eisai Co., Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • H. Lundbeck A/S
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Axsome Therapeutics, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Taisho Pharmaceutical Holdings Co., Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Kissei Pharmaceutical Co., Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • NLS Pharmaceutics Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  10. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  11. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on Orexin Receptor Agonist Therapeutics Market' - Global forecast to 2033